Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01580046

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Yong Huo (from the registry)
Registry
  • NCT NCT01580046
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01580046. Randomized; single masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
Acronym
RIPE
Condition
Kidney Failure, Chronic
Intervention (Drug)
iodixanol
Intervention (Drug)
iopromide
Lead sponsor
Yong Huo (class: other)

Record details

Record id
cardio:ct-nct01580046
Content hash
8ef62d5ffb080e36bd4e54ef772b4ea163bc40d4de1f3be8c36491d4c08feeb3